1. Home
  2. CTMX vs SNAL Comparison

CTMX vs SNAL Comparison

Compare CTMX & SNAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • SNAL
  • Stock Information
  • Founded
  • CTMX 2008
  • SNAL 2000
  • Country
  • CTMX United States
  • SNAL United States
  • Employees
  • CTMX 122
  • SNAL N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • SNAL Computer Software: Prepackaged Software
  • Sector
  • CTMX Health Care
  • SNAL Technology
  • Exchange
  • CTMX Nasdaq
  • SNAL Nasdaq
  • Market Cap
  • CTMX 62.3M
  • SNAL 92.8M
  • IPO Year
  • CTMX 2015
  • SNAL 2022
  • Fundamental
  • Price
  • CTMX $0.80
  • SNAL $2.72
  • Analyst Decision
  • CTMX Buy
  • SNAL
  • Analyst Count
  • CTMX 6
  • SNAL 0
  • Target Price
  • CTMX $5.77
  • SNAL N/A
  • AVG Volume (30 Days)
  • CTMX 730.8K
  • SNAL 146.8K
  • Earning Date
  • CTMX 03-10-2025
  • SNAL 03-31-2025
  • Dividend Yield
  • CTMX N/A
  • SNAL N/A
  • EPS Growth
  • CTMX N/A
  • SNAL N/A
  • EPS
  • CTMX 0.16
  • SNAL 0.08
  • Revenue
  • CTMX $126,617,000.00
  • SNAL $86,822,973.00
  • Revenue This Year
  • CTMX $22.55
  • SNAL $39.43
  • Revenue Next Year
  • CTMX N/A
  • SNAL $26.12
  • P/E Ratio
  • CTMX $5.14
  • SNAL $35.99
  • Revenue Growth
  • CTMX 33.66
  • SNAL 82.23
  • 52 Week Low
  • CTMX $0.75
  • SNAL $0.52
  • 52 Week High
  • CTMX $5.85
  • SNAL $3.42
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 41.61
  • SNAL 57.64
  • Support Level
  • CTMX $0.75
  • SNAL $2.61
  • Resistance Level
  • CTMX $0.98
  • SNAL $3.42
  • Average True Range (ATR)
  • CTMX 0.06
  • SNAL 0.34
  • MACD
  • CTMX 0.00
  • SNAL 0.03
  • Stochastic Oscillator
  • CTMX 20.13
  • SNAL 60.92

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About SNAL Snail Inc.

Snail Inc is a global independent developer and publisher of interactive digital entertainment for consumers around the world, with a premier portfolio of premium games designed for use on a variety of platforms, including consoles, PC's, and mobile devices. The geographic presence of the company is in the United States and the International market, where the majority of its revenue comes from the United States.

Share on Social Networks: